Published on:

Investor Complaints: IGI Laboratories, Inc. (IG)

IGI LaboratoriesThe securities and investment fraud law firm, Fitapelli Kurta, is interested in speaking to investors who have complaints regarding IGI Laboratories, Inc. (IG) offered by Maxim Group, LLC

IGI Laboratories, Inc. (IG) is a generic pharmaceutical company traded on the New York Stock Exchange (NYSE). In April 2015 IGI shares lost 30% of their value. Jason Grenfell-Gardner is the CEO of IGI Laboratories, Inc. (IG).

Maxim Group, LLC is a New York based independent broker-dealer firm registered with the SEC and FINRA. Maxim Group, LLC has offices in 53 U.S. states and territories. Maxim Group, LLC has 15 regulatory events disclosed on its BrokerCheck Report.

If you or someone you know has a complaint regarding IGI Laboratories, Inc. (IG) through Maxim Group, LLC or any other independent broker-dealer firm, call the attorneys at Fitapelli Kurta at 877-238-4175 now for your free consultation.  You may be able to recover your losses.

Our cases are taken on a contingency fee basis, which means we do not get paid unless you recover money.

Time is of the essence, so do not delay. Call 877-238-4175 to speak to an attorney for free